An independent guide to cash-pay care. Every price is dated and sourced.

How we check

Oral tirzepatide: what exists and what does not

There is no FDA-approved oral tirzepatide. The FDA-approved tirzepatide products, Zepbound and Mounjaro, are once-weekly injections [1] [2]. Tirzepatide drops, lozenges or tablets sold online are compounded or unapproved products that FDA has not reviewed for safety, effectiveness or quality [3]. Two GLP-1 pills are FDA-approved for weight loss, and neither contains tirzepatide: Foundayo (orforglipron) and the Wegovy pill (semaglutide) [4] [5].

Medical review: pending. A licensed clinician has not yet reviewed this page.

Oral tirzepatide means tirzepatide taken by mouth as a tablet, drop or lozenge; no such product is FDA-approved, and approved tirzepatide is injected under the skin.

FDA-approved oral tirzepatide
None; Zepbound and Mounjaro are injections [1] [2]
Approved GLP-1 pills for weight
Foundayo (approved April 1, 2026) and Wegovy pill (announced December 22, 2025) [4] [5]
Foundayo self-pay
$149 to $299 a month on LillyDirect, checked Oct 17, 2026 [6]
Wegovy pill self-pay
$149 to $299 a month on NovoCare, checked Oct 17, 2026 [7]
Compounded tirzepatide reports to FDA
More than 730 adverse event reports by May 31, 2026 [3]

What exists: tirzepatide is an injection

Both FDA labels for tirzepatide list only injectable forms: single-dose pens, single-dose vials, KwikPens and multi-dose vials, given under the skin once a week [1] [2]. The Zepbound label reports that about 80% of an injected dose reaches the bloodstream [8]. No FDA label gives any absorption figure for tirzepatide taken by mouth, because no oral product has been approved.

What online "oral tirzepatide" products are

Products marketed as oral, sublingual or drop forms of tirzepatide, or as oral "GLP-1" products, fall into a few groups. None is FDA-approved.

  • Compounded products from telehealth companies. Pharmacies make these for individual prescriptions. FDA does not review compounded drugs for safety, effectiveness or quality [3]. Examples we saw on October 17, 2026: Direct Meds references oral compounded tirzepatide on its site [9]; Shed sells "GLP-1" liquid drops from $229 a month and sublingual lozenges from $199 a month [10]; Mochi Health lists compounded orforglipron, the ingredient in Foundayo, from $31 plus membership [11]. See our reviews of Direct Meds, Shed and Mochi Health.
  • Unapproved products sold directly. In December 2024, FDA warned Veronvy over unapproved, misbranded oral GLP-1 products, one of which claimed FDA approval [12].
  • "Research use only" powders. FDA has warned sellers of tirzepatide labeled for research or "not for human consumption" that was sold to consumers with dosing directions; quality is unknown and may be harmful [3]. See research-use-only GLP-1s.

FDA's main consumer page on unapproved GLP-1 drugs, updated October 1, 2026, does not single out oral versions [3]. Its general points still apply: FDA had more than 730 adverse event reports for compounded tirzepatide by May 31, 2026, and says the true number is likely higher [3].

Does oral or sublingual tirzepatide work?

There is no FDA-reviewed evidence that it does. The trials behind Zepbound, such as SURMOUNT-1, tested weekly injections [13]. We found no trial of an oral, sublingual or drop form of tirzepatide in our research. The weight-loss numbers you see quoted for tirzepatide, such as 20.9% at 72 weeks on 15 mg [13], come from the injection and cannot be applied to a product taken by mouth.

FDA declared the tirzepatide shortage over on December 19, 2024. Since then, 503A pharmacies may compound it only for individual patients, and "essentially copies" of approved drugs are barred unless a prescriber documents a change that makes a significant difference for that patient. 503B outsourcing facilities cannot make it from bulk ingredient at all [14]. In February 2026, FDA said it intends to restrict GLP-1 ingredients used in non-approved compounded drugs [15]. In September 2026 it warned Empower Pharmacy that tirzepatide/niacinamide products were essentially copies and questioned templated "personalization" [16]. Whether a given oral product is lawful is a legal question we cannot settle, but none of these rules makes it FDA-approved. More on compounded tirzepatide.

Red flags in oral tirzepatide ads

FDA tells telehealth companies not to call compounded drugs generic, the same as an approved drug, FDA-approved, or clinically proven to give the same results, and not to claim an "FDA-approved" or "FDA-licensed" pharmacy [17]. An ad that does any of this is making a claim FDA calls misleading. Our FDA warning letter tracker lists companies that have been warned.

The GLP-1 pills that are FDA-approved

FDA-approved GLP-1 pills for weight, with Zepbound for comparison
ProductDrug and makerHow takenLabel weight resultSelf-pay price (checked Oct 17, 2026)
FoundayoOrforglipron, Eli Lilly; approved April 1, 2026 [4]Once daily, 0.8 to 17.2 mg, with or without food [18]-11.1% on 17.2 mg vs -2.1% placebo at 72 weeks [18]$149 to $299 a month [6]
Wegovy pillSemaglutide, Novo Nordisk; approval announced December 22, 2025 [5]Once daily, 1.5 to 25 mg, empty stomach with up to 4 oz water, wait 30 minutes [19]Not in our sources$149 to $299 a month [7]
Zepbound (injection)Tirzepatide, Eli LillyOnce weekly, 2.5 to 15 mg [1]-20.9% on 15 mg vs -3.1% placebo at 72 weeks [8]$299 to $449 a month [20]
Results come from separate trials and are not a head-to-head comparison. Foundayo 2.5 mg and 5.5 mg prices are temporarily reduced through December 31, 2026, and its 14.5 mg and 17.2 mg prices require refills within 45 days [6].

Foundayo is made by the same company as Zepbound, but it is a different molecule, not a tirzepatide pill [18]. Compare them on Foundayo vs Wegovy pill, Foundayo, Wegovy pill and Wegovy pill vs injection.

If you want to avoid needles

Ask a prescriber whether one of the approved pills fits you. If tirzepatide specifically is the goal, the approved route is a weekly injection; see how to use tirzepatide and tirzepatide cost. Both approved pills and tirzepatide carry boxed warnings about thyroid C-cell tumors [18] [19] [8]. For severe stomach pain that will not go away on any GLP-1, stop and call your prescriber; call 911 for trouble breathing or swelling of the face or throat [21].

Questions people ask

Is there an oral tirzepatide?

Not an FDA-approved one. The approved tirzepatide products, Zepbound and Mounjaro, are once-weekly injections [1] [2]. Oral tirzepatide sold online is compounded or unapproved and not reviewed by FDA [3].

Does oral tirzepatide work?

There is no FDA-reviewed evidence that it does. The tirzepatide trials, including SURMOUNT-1, tested weekly injections [13], and no label gives absorption data for tirzepatide by mouth.

What are tirzepatide drops or lozenges?

They are compounded or unapproved products sold online, often through telehealth. FDA does not review compounded drugs for safety, effectiveness or quality [3].

Is compounded oral tirzepatide legal?

Since the shortage ended on December 19, 2024, FDA allows 503A pharmacies to compound tirzepatide only for individual patients and bars routine copies of approved drugs; 503B facilities cannot use bulk tirzepatide [14]. No compounded form is FDA-approved.

Which GLP-1 pills are FDA-approved for weight loss?

Foundayo (orforglipron), approved April 1, 2026 [4], and the Wegovy pill (oral semaglutide), whose approval Novo Nordisk announced on December 22, 2025 [5].

How much do the approved GLP-1 pills cost?

Self-pay prices checked October 17, 2026: Foundayo $149 to $299 a month on LillyDirect [6] and the Wegovy pill $149 to $299 a month on NovoCare [7], depending on dose.

Is Foundayo a tirzepatide pill?

No. Foundayo is orforglipron, a different once-daily GLP-1 drug from Eli Lilly, the maker of Zepbound [18]. In its label trial, people on 17.2 mg lost 11.1% vs 2.1% on placebo at 72 weeks [18].

Sources

21 cited
  1. Zepbound (tirzepatide) label, revised 8/2026. DailyMed, U.S. National Library of Medicine, Aug 28, 2026.
  2. Mounjaro (tirzepatide) label, revised 8/2026. DailyMed, U.S. National Library of Medicine, Aug 27, 2026.
  3. FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
  4. Foundayo (orforglipron) NDA 220934 approval letter. U.S. Food and Drug Administration, Apr 1, 2026.
  5. Wegovy pill FDA approval announcement. Novo Nordisk, Dec 22, 2025.
  6. Foundayo on LillyDirect: self-pay prices. Eli Lilly and Company, Oct 17, 2026.
  7. Wegovy self-pay offer. Novo Nordisk (NovoCare), Oct 17, 2026.
  8. Zepbound (tirzepatide) prescribing information, revised 04/2026. U.S. Food and Drug Administration, Apr 2026.
  9. Direct Meds pricing. Direct Meds, Oct 17, 2026.
  10. Shed weight loss product listing. Shed, Oct 17, 2026.
  11. Mochi Health home page. Mochi Health, Oct 17, 2026.
  12. FDA Roundup: December 17, 2024. U.S. Food and Drug Administration, Dec 17, 2024.
  13. SURMOUNT-1 trial abstract (Jastreboff et al., NEJM 2022). New England Journal of Medicine, via PubMed, Jun 4, 2022.
  14. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. U.S. Food and Drug Administration, Apr 1, 2026.
  15. FDA intends to take action against non-FDA-approved GLP-1 drugs. U.S. Food and Drug Administration, Feb 6, 2026.
  16. Warning letter to Empower Clinic Services LLC dba Empower Pharmacy. U.S. Food and Drug Administration, Sep 18, 2026.
  17. Telehealth companies: what to know when promoting compounded drugs. U.S. Food and Drug Administration, Jun 15, 2026.
  18. Foundayo (orforglipron) prescribing information, revised 7/2026. Eli Lilly and Company, Jul 2026.
  19. Wegovy (semaglutide) injection and tablets label, revised 6/2026. DailyMed, U.S. National Library of Medicine, Jun 18, 2026.
  20. Zepbound on LillyDirect: self-pay prices. Eli Lilly and Company, Oct 17, 2026.
  21. Zepbound Medication Guide and Patient Information. DailyMed, U.S. National Library of Medicine, Aug 28, 2026.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

Compare the approved GLP-1 pills